StockWatch
·
Specialty Chemicals
Quarterly Result28 May 2026, 10:51 pm

513353 Q4/FY26 Audited Results Approved; 80% Dividend Recommended

AI Summary

The Board of Directors of 513353 approved the Audited Standalone Financial Results for the quarter and year ended March 31, 2026. Concurrently, the Board recommended a final dividend of 80% (₹8/- per equity share of ₹10/- paid up), subject to shareholder approval at the upcoming Annual General Meeting. Additionally, Mr. Rajesh Jacob (DIN: 06443594) was appointed as a Nominee Director, effective May 28, 2026. The Board also approved the continuation of Mr. Mathew M Cherian (DIN: 01265695) as a Non-Executive Director after he attains 75 years, subject to shareholder approval. The auditors issued an unmodified opinion on the financial results.

Key Highlights

  • Board approved Audited Standalone Financial Results for Q4 and FY26.
  • Recommended final dividend of 80% (₹8/- per share).
  • Mr. Rajesh Jacob appointed as Nominee Director.
  • Mr. Mathew M Cherian's continuation as Non-Executive Director approved.
  • Auditors issued an unmodified opinion on the financial results.